Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Glassia
1.4.3 Aralast NP
1.4.4 Prolastin C
1.4.5 Others
1.5 Market by Application
1.5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Regions
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (2019-2025)
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by by Players
3.1.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.3 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
3.4 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019)

5 North America
5.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
5.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in North America
5.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
5.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

6 Europe
6.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
6.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Europe
6.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
6.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
7.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
7.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

8 International Players Profiles
8.1 Grifols
8.1.1 Grifols Company Details
8.1.2 Company Description and Business Overview
8.1.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019))
8.1.5 Grifols Recent Development
8.2 CSL
8.2.1 CSL Company Details
8.2.2 Company Description and Business Overview
8.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.2.5 CSL Recent Development
8.3 Baxter
8.3.1 Baxter Company Details
8.3.2 Company Description and Business Overview
8.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.3.5 Baxter Recent Development
8.4 Kamada
8.4.1 Kamada Company Details
8.4.2 Company Description and Business Overview
8.4.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.4.5 Kamada Recent Development
8.5 Takeda
8.5.1 Takeda Company Details
8.5.2 Company Description and Business Overview
8.5.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.5.5 Takeda Recent Development
8.6 Abeona
8.6.1 Abeona Company Details
8.6.2 Company Description and Business Overview
8.6.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.6.5 Abeona Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Market Segments
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Covered
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Glassia Figures
Table Key Players of Glassia
Figuer Aralast NP Figures
Table Key Players of Aralast NP
Figuer Prolastin C Figures
Table Key Players of Prolastin C
Figuer Others Figures
Table Key Players of Others
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players in 2018
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
Table Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2014-2019)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application in 2018
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Table Grifols Company Details
Table Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Grifols Recent Development
Table CSL Company Details
Table CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table CSL Recent Development
Table Baxter Company Details
Table Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Baxter Recent Development
Table Kamada Company Details
Table Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Kamada Recent Development
Table Takeda Company Details
Table Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Takeda Recent Development
Table Abeona Company Details
Table Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Abeona Recent Development
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions in 2025
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product in 2025
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Grifols、CSL、Baxter、Kamada、Takeda、Abeona

【免責事項】
https://www.globalresearch.jp/disclaimer